Lv3受限
330 积分 2021-11-04 加入
177Lu-DOTATATE versus high-dose long-acting octreotide for somatostatin receptor-positive advanced GEP-NETs: A multicenter, randomised, open-label, positive-controlled phase III study
20天前
已完结
177Lu-Dotatate versus high-dose long-acting octreotide for the treatment of patients with advanced, grade 1-2, well-differentiated gastroenteropancreatic neuroendocrine tumours (XT-XTR008-3-01): an open-label, randomised, phase III trial
20天前
已完结
Causes of death among patients with metastatic differentiated thyroid cancer
21天前
已完结
Abstract 3360: Targeted catalytic inhibition of EZH2 synergizes with low-dose HDACi in malignant rhabdoid tumors
1个月前
已关闭
Reagent for the Chemoselective Reduction of Carboxylic Acids to Aldehydes
6个月前
已完结
皖公网安备34019202002308
